From the Sector

Patients as well as air-condition and ventilator systems spread SARS-CoV-2 virus as aerosols which settle on surfaces and remain there infective for more than 72 hours. That‘s why the pandemic has triggered an intensive search for Personal Protective Equipment PPE whose surfaces have antiviral properties, e.g. are able to bind and inactivate adhering virus.

In this context the chemical stability of the materials being used for PPE, polypropylene PP and/or polyester PET, is a challenge. More precisely, the absence of so-called ‘functional groups‘, like -OH, -COO-, -NH3+ at the material‘s surface. These groups are the fundamental basis for surface chemistry – specifically for attaching antiviral compounds onto the surfaces of man-made fibers.

Antiviral surface modification with the basic amino acid Arginine Arg is a new approach to inactivate SARS-CoV-2. - bionic surfaces‘ - development was tested according to ISO 18184:2019 „Determination of antiviral activity of textile products“ at Institute for Virology and Immunology at University Wuerzburg, Germany. - The finding: „[Six hours] incubation on [Arginine] coated NW reduced viral infectivity by more than five orders of magnitude.“ In other words: An amount of, for example, 10.000.000 virus is reduced to 100 (by five orders of magnitude).

- bionic surfaces – has more than 30 years experience in wet-chemical surface modification of man-made polymers like PDMS, PP, PE, PTFE.

U.S. Senator Sherrod Brown (D-OH) and U.S. Representative Kathy Manning (D-NC) wrote to President Biden calling on the Administration to prioritize purchasing fully made in America Personal Protective Equipment (PPE). The lawmakers outline four steps the Administration can take now to ensure our frontline workers have products needed to effectively carryout their critical responsibilities and to support domestic manufacturers who are ready to scale up production and help keep workers healthy and safe.

In their letter, Brown and Manning call on President Biden, through Executive Order and legislative efforts, to:

1. Prioritize the purchase of fully made in America PPE “Berry compliant” to help continue bolstering the U.S. supply chain regardless of purchasing agency;
2. Issue long-term contracts directly to domestic manufacturers when possible to help bolster the domestic supply chains;
3. Adopt a contracting purchase methodology that uses “Best Value” criteria versus “Lowest Price Technically Acceptable” criteria; and
4. Designate a point person in charge of coordinating the government’s efforts to procure PPE and other medical equipment who is responsible for meeting regularly with key domestic manufacturing stakeholders.

A full copy of Brown and Manning’s letter can be found here.

Archroma, a global leader in specialty chemicals towards sustainable solutions, today announced an increase of up to 20% in the selling prices of its Nuva^® N and Fluowet^® fluorocarbon polymers.

Fluorocarbon polymers are typically used in essential applications where a water and/or oil barrier is needed, such as personal protective equipment (PPE) for health professionals, or other technical textiles.

As a global leader in the area of repellency treatments, we have the responsibility to develop and produce products with the highest level of sustainability – economically and ecologically.

The price increase has become necessary to support the increasing regulatory and other costs, as well as ongoing investments that Archroma continuously makes in its own manufacturing technology and process, to produce fluorochemicals in the safest possible way for the consumer and the environment.

The price increase will be effective from November 16, 2020, in all regions and markets, for all new orders and as contracts allow.

® Trademarks of Archroma registered in many countries

Archroma, a global leader in color and specialty chemicals towards sustainable solutions, has joined hands with Liberty Textile Mill Limited (Liberty), a leading producer in healthcare textiles to produce high quality personal protective equipment (PPE).

Liberty will be benefitting from Archroma’s specialty solutions for hygiene protection, and well-established technical expertise in the area of medical textiles. Amidst the COVID-19 pandemic, the PPEs manufactured by Liberty are aimed at easing the current shortage of PPEs for medical professionals in Pakistan.

Liberty carries over two decades of experience in medical textiles and exporting them all over the world. Its partnering with Archroma is a major step forward towards creating enhanced protection in the current crisis. With its advanced scientific knowledge and technical expertise, Archroma provides a complete set of specialty chemicals required to produce PPEs, in particular in the area of antimicrobial and barrier coatings. The project will assist in enhancing medical standards in hospitals, isolation centers and intensive care units, in Pakistan and, very soon, worldwide.

“By continuously challenging the status quo, we at Archroma are able to support our customers operating in or entering the area of medical textiles, with a holistic and expert approach to hygiene protection. With our collaboration with Liberty, we are so proud to be able to bring state-of-the art protection to health professionals and the general public,” comments Mujtaba Rahim, CEO of Archroma Pakistan.

“Liberty has a presence of more than five decades with high achieving accolades. Our processing units are fully equipped with latest equipment complying with international standards. We take this new partnership with Archroma as a start of building a strong relationship in the area of medical textiles. The COVID-19 pandemic has given a wake-up call to work extensively towards enhancing healthcare facilities. We are looking forward to new innovations in producing top-class PPEs,” adds Taimoor Mukaty, Director of Liberty Textile Mills Limited.

National Council of Textile Organizations (NCTO) President and CEO Kim Glas issued a statement, urging the government to institute Buy American policy changes to help bolster U.S. manufacturers producing personal protective equipment (PPE) for frontline workers battling the COVID-19 pandemic.

“If the government is sincere about reconstituting a U.S. production chain for medical personal protective equipment (PPE) to resolve the drastic shortages we are experiencing during the current pandemic, it is going to have to make key policy changes to help incentivize domestic production. A strong Buy American mandate for these vital healthcare materials needs to be instituted for all federal agencies, coupled with other reasonable production incentives, to help ensure a strong U.S.  manufacturing base for these essential products.

Our government already has an existing example of such a mandate that serves as an excellent model. The U.S. Department of Defense operates under a fiber-to-finished product Buy American rule for military textiles. This rule ensures that the vital textile materials our U.S. warfighters depend upon, come from a secure domestic production chain that cannot be severed during a military emergency by offshore entities.

There is a bipartisan call for action as members of Congress on both sides of the aisle have begun to acknowledge the need for these types of reasonable and essential policy changes.

Anything short of fully instituting domestic purchase requirements through Executive Order and other legislative initiatives will ensure that PPE production through U.S. supply chains that have been created overnight don’t evaporate as soon as this crisis is over.  

In the midst of the crisis, our failure to confront this challenge will allow for a repeat of the sins of the past that allowed sourcing agents to offshore the entire production of medical PPE in search of lucrative profits. While chasing the lowest cost import may have seemed cost effective at the time, these past few months have demonstrated that we paid a deadly price through this approach by jeopardizing the very lives of frontline medical personnel that are fighting the pandemic.   

This is a national security issue. It’s also a vital healthcare issue and it is decision time for U.S. policymakers. If our country is to be prepared for future deadly pandemics such as the one it is now facing, reasonable policy changes need to be implemented to ensure that we strengthen our domestic supply chain to address America’s security, safety and healthcare requirements.”

NCTO is a Washington, DC-based trade association that represents domestic textile manufacturers, including artificial and synthetic filament and fiber producers. 

The National Council of Textile Organizations (NCTO), representing the full spectrum of U.S. textiles from fiber through finished products, issued a statement from NCTO President and CEO Kim Glas today, voicing concern over the administration’s executive order instituting a non-reciprocal 90-day deferral on certain tariffs.
The temporary postponement of duties does not apply to products with antidumping or countervailing duties or those products subject to penalty duties under Section 232, 201 and 301.

“At a time when domestic textile producers and its workforce have mobilized to transform their production lines to manufacture the personal protective equipment (PPE) supplies for frontline healthcare and medical workers fighting the COVID-19 pandemic, the administration’s decision to defer duties for 90 days on the vast majority of products imported into the United States is counterproductive.
This move contradicts the administration’s top stated priority of rebuilding American manufacturing and buying American and could have severe negative implications for the entire U.S. textile industry, whose companies and workforce already are facing enormous economic hardship.
We support the need to temporarily eliminate barriers to the entry of emergency medical supplies and certain PPE inputs tied directly to the COVID-19 response. But make no mistake, the key drivers behind efforts to defer tariffs have nothing to do with facilitating access to PPE products or stopping the spread of COVID-19.
Our industry is being asked to do extraordinary things.  We are heeding that call, but we need help to ensure the supply chains we are creating overnight don’t evaporate tomorrow.  We need strong procurement policies and additional funding for our industries to ramp up and retool – not further measures that incentivize offshore production. We need to maximize the U.S. domestic production chain right now to every extent possible in helping fight COVID-19 and make the products American frontline workers desperately need.  

We need to provide immediate and substantial relief to our manufacturing sector and their workforce who are suffering enormously right now. It’s critical that we have a long-term U.S. government plan to ensure that we aren’t relying on offshore producers to make medically necessary, live-saving PPE.  We shouldn’t be providing handouts to reward the very companies that helped offshore these industries so many years ago.

Tariffs are one of the few mechanisms in place to help partially address the challenges U.S. manufacturers face in competing with imports from countries with exceptionally low wages, poor working conditions, and minimal environmental and safety standards.”, states the NCTO.

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

For over 40 years, Burlington has been in the Medical business manufacturing fabrics for use in operating theaters such as surgeon’s gowns, isolation gowns, sterilization wrapper packs, drapes, scrubs and lab coats. The Maxima® collection of fabrics is useful for reusable isolation and surgical gowns and meets AAMI standards for Levels 1-4 and FDA standards.

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods. This will create significant hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items.

We are asking the administration and state and local authorities to provide greater certainty and clarity for our companies and employees and ask for a clear exclusion of our manufacturing operations from “Shelter in Place” orders as the textile and nonwoven products that we make in the U.S. play an essential role in mitigating the shortages of critical supplies. Such a designation will help us avoid disruptions of vital goods and services during this challenging time.

Myant Inc. and Osmotex AG have agreed to enter into a joint venture for the commercialization of Osmotex’s HYDRO_BOT active membrane technology across various textile-based applications. The integration of HYDRO_BOT with Myant’s existing portfolio of textile-based sensing and actuating capabilities opens up new possibilities across a wide range of domains including sweat/moisture management and thermal regulation.

HYDRO_BOT technology is capable of moving 200 liters of fluid across a square meter of textile every hour via an electroosmotic process, providing a practically limitless ability to manage moisture in textile applications. Applied in conjunction with Myant’s existing capability to deliver heat via textile and to achieve effective passive moisture wicking via novel knitted structures, the combination of technologies is poised to dramatically improve the ability to regulate body temperature in applications such as personal protective equipment for workers in heavy industry, protective gear for workers in hot desert-like climates, performance wear like snow suits or skiing apparel in cold climates, footwear, motorcycling apparel, and more. In addition to apparel, significant market opportunities exist in the moisture management as applied to the automotive industry and in the healthcare industry.

“The creation of this joint venture between Myant and Osmotex reinforces our mission to develop textiles as bidirectional interfaces to the human body capable of optimizing health and performance across all spheres of life,” said Tony Chahine, founder and CEO of Myant. “Our team is excited to begin integrating HYDRO_BOT into our textiles and bringing this transformative technology to market.”

“We are excited to be working together with Myant to realize the full potential of the HYDRO_BOT technology,” said Joacim Holter, Managing Director and Chairman of the Board for Osmotex AG. “Myant’s ability to integrate our technology and to produce at scale all under one roof made them an ideal partner to help make our vision a reality.”